Showing results (531-540 of 794) with videos related to
Sort By:
Pageof 80
Magnetic Resonance Imaging|January 1, 1994
Proton spectroscopy in HIV infection: relaxation times of cerebral metabolitesI D Wilkinson, M Paley, W K Chong, et al.IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|March 11, 2009
Estimation of effective and functional cortical connectivity from neuroelectric and hemodynamic recordingsLaura Astolfi, F De Vico Fallani, F Cincotti, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 9, 2011
Quality of life after immediate breast reconstruction and skin-sparing mastectomy - a comparison with patients undergoing breast conserving surgeryH M Heneghan, R S Prichard, R Lyons, et al.Cancer Cytopathology|April 23, 2016
A superior method for cell block preparation for fine-needle aspiration biopsiesRonald Balassanian, Geoffrey D Wool, Jill C Ono, et al.Journal of the National Cancer Institute|November 3, 2025
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experimentRafael Emilio De Feria Cardet, Stephen Goodall, Tracey-Lea Laba, et al.Lancet (London, England)|September 6, 2005
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialKishan J Pandya, Gary R Morrow, Joseph A Roscoe, et al.Molecular Cancer Therapeutics|June 2, 2007
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivoMichele T Yip-Schneider, Huangbing Wu, Matthew Ralstin, et al.Cancer|January 6, 2017
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancerBrandon Bernard, Vinayak Muralidhar, Yu-Hui Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|May 18, 2016
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expressionKazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara, et al.European Urology Oncology|April 30, 2024
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, et al.Pageof 80